• Home
• Register for Updates
• Contact Us

NASDAQ: 12.03 +0.00 +0% Volume: 32,100 May 16, 2012

• About Us
  • Overview
  • Message from CEO
  • Ligand Leadership
  • Board of Directors
  • Scientific Advisors
• Pipeline
• Promacta
• Our Collaborations
  • Overview
  • Collaborations
  • Royalties
• Licensing Opportunities
  • Overview
  • SARM
  • Diabetes Portfolio
  • Captisol-Enabled Melphalan
  • EPO/GCSF
  • IRAK4
  • Contact Business Development
• Investors
  • Investor Overview
  • News & Events
    • Press Releases
    • Investor Calendar
    • Webcasts & Presentations
  • Analyst Coverage
  • SEC Filings
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Price Lookup
  • Corporate Governance
  • Email Alerts
  • Contact Us
  • RSS Feeds
• Captisol

• 
  E-mail Page
  |
• 
  RSS Feeds
  |
• 
  E-mail Alerts
  |
• 
  Financial Tear Sheet

• Terms of Use
• Site Map

Powered By Q4 Web Systems 3.6.2.3937